Published in Clin J Am Soc Nephrol on February 25, 2010
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol (2010) 1.52
Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol (2011) 1.47
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Phosphate additives in food--a health risk. Dtsch Arztebl Int (2012) 1.33
Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr (2013) 1.27
Survival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity. Semin Dial (2010) 1.18
Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol (2011) 1.16
Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.16
Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients. J Ren Nutr (2011) 1.11
Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients. Int Urol Nephrol (2011) 1.10
Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence (2013) 0.99
Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens (2012) 0.95
Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr (2013) 0.92
Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr (2011) 0.92
Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone (2014) 0.92
Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant (2011) 0.90
Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial (2015) 0.89
Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study. J Ren Care (2011) 0.85
A wearable artificial kidney for patients with end-stage renal disease. JCI Insight (2016) 0.85
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol (2013) 0.84
Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients. Clin J Am Soc Nephrol (2011) 0.84
Phosphorus and nutrition in chronic kidney disease. Int J Nephrol (2012) 0.84
Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study. PLoS One (2015) 0.83
Design and development of a dialysis food frequency questionnaire. J Ren Nutr (2010) 0.83
Estimate of dietary phosphorus intake using 24-h urine collection. J Clin Biochem Nutr (2014) 0.82
Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control. Int J Nephrol (2011) 0.80
Management of hyperphosphataemia in chronic kidney disease-challenges and solutions. Clin Kidney J (2013) 0.80
Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations. Kidney Res Clin Pract (2015) 0.79
Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011) (2013) 0.79
Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol (2015) 0.79
Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study. PLoS One (2015) 0.78
Management of phosphorus load in CKD patients. Clin Exp Nephrol (2016) 0.78
Assessment of dietary intake of children with chronic kidney disease. Pediatr Nephrol (2016) 0.78
Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study. BMC Nephrol (2013) 0.76
Factors associating with oxygenation of lower-limb muscle tissue in hemodialysis patients. World J Nephrol (2016) 0.75
The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey. PLoS One (2016) 0.75
Availability of 24-h urine collection method on dietary phosphorus intake estimation. J Clin Biochem Nutr (2016) 0.75
Nocturnal eating disturbs phosphorus excretion in young subjects: a randomized crossover trial. Nutr J (2015) 0.75
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Flexible regression models with cubic splines. Stat Med (1989) 14.45
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19
Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol (1990) 8.70
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol (2004) 6.59
A reduced dietary questionnaire: development and validation. Epidemiology (1990) 5.41
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med (2000) 3.96
Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc (1992) 3.91
Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol (2002) 3.83
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Nephron adaptation to renal injury or ablation. Am J Physiol (1985) 2.65
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol (2005) 2.51
Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA (2009) 2.44
Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation (1997) 2.32
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr (1993) 2.06
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant (2002) 2.05
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis (2008) 1.78
Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.75
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest (1996) 1.63
Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial (2007) 1.51
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis (2005) 1.49
Validation of a food frequency questionnaire for Hispanics. Prev Chronic Dis (2006) 1.43
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr (2005) 1.39
Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.36
Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol (2005) 1.28
Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr (2002) 1.24
Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol (2009) 1.20
Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant (1999) 1.19
Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol (2002) 1.19
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol (1994) 1.17
Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis (2002) 1.10
Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol (2010) 1.10
Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol (2008) 1.09
Anthropometric norms for the dialysis population. Am J Kidney Dis (1990) 1.05
Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr (1999) 1.03
Phosphorus balance with daily dialysis. Semin Dial (2007) 0.96
Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient. Kidney Int (1999) 0.93
A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif (2004) 0.92
Hyperphosphatemia and vascular calcification in end-stage renal disease. J Ren Nutr (2005) 0.91
How should hyperphosphatemia be managed in dialysis patients? Semin Dial (2002) 0.86
Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol (1999) 0.86
Adaptation to changes in dietary phosphorus intake in health and in renal failure. J Lab Clin Med (1997) 0.85
Chronic renal failure is a state of cellular calcium toxicity. Am J Kidney Dis (1993) 0.83
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis. Kidney Int Suppl (2005) 0.78
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Cachexia: a new definition. Clin Nutr (2008) 5.49
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med (2008) 4.98
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med (2010) 3.78
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation (2009) 3.43
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Does AKI truly lead to CKD? J Am Soc Nephrol (2012) 2.61
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc (2010) 2.55
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis (2005) 2.47
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med (2013) 2.18
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant (2006) 2.15
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial (2014) 2.02
The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int (2009) 1.98
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl (2010) 1.91
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation (2012) 1.86
Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol (2009) 1.85
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr (2009) 1.83
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis (2010) 1.82
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension (2005) 1.80
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis (2009) 1.79
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79
Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis (2008) 1.78
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis (2003) 1.77
Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis (2011) 1.77
Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol (2006) 1.76
Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr (2004) 1.75
A1C and survival in maintenance hemodialysis patients. Diabetes Care (2007) 1.75
Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.75
Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis (2011) 1.74
Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int (2007) 1.71
Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant (2004) 1.71
Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol (2012) 1.67
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant (2006) 1.65
Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis (2010) 1.64
Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis (2007) 1.63
Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc (2010) 1.63
Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol (2013) 1.63
Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant (2008) 1.62
Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am J Hypertens (2011) 1.60
Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial (2005) 1.58